Close Menu

An article from yesterday's New York Times details the coming challenges in deriving food from genetically modified organisms, particularly here in the US, where so far there aren't a lot of guidelines on the subject. Getting FDA to "spell out the rules of the game," the article says, could be the encouragement investors need to get active in this area -- while others contend that such guidelines would scare the public by having the GMO term associated with this food.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.